Standard & Poor’s will make the following changes in the S&P/TOPIX 150 and S&P Japan 500 Indices effective after the close of trading Friday, June 27, 2008:
- Takeda Pharmaceutical Co., Ltd. (Japan, SEDOL: 6870445, GICS: Health Care, GICS Code: 35202010) a member of the S&P/TOPIX 150 and S&P Japan 500 indices, shares will decrease by 57,130,000 to 832,142,395 due to the repurchase of shares.
|
S&P Japan 500 and S&P/TOPIX 150 – June 27, 2008 after the market close- |
||
|
S&P Index |
Company |
New Shares |
|
S&P/TOPIX 150 |
Takeda Pharmaceutical Co., Ltd. |
832,142,395 |
About Standard & Poor’s
Standard & Poor's is the world's foremost provider of independent credit ratings, indices, risk evaluation, investment research, data and valuations. With approximately 8,500 employees located in 23 countries, Standard & Poor's is an essential part of the world's financial infrastructure and has played a leading role for more than 140 years in providing investors with the independent benchmarks they need to feel more confident about their investment and financial decisions. For more information, visit www.standardandpoors.com.
